LBA3 First-line HLX07 vs. placebo combined with serplulimab and chemotherapy for nasopharyngeal cancer: A randomised, double-blind, multicentre phase II study.

Autor:	Zhang, L.1 (AUTHOR), Fang, W.F.1 (AUTHOR), Ai, X.2 (AUTHOR), Lei, F.3 (AUTHOR), Ma, D.4 (AUTHOR), Ni, H.5 (AUTHOR), Hou, X.5 (AUTHOR), Wang, Q.5 (AUTHOR), Yu, H.5 (AUTHOR), Li, J.5 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1554-S1554. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu